Rodrigo Vieira, MD
Psychiatry · Houston, TXNPI 1558807818
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,060 of the $16,901 with a category attached, or 71.4%. 8 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 29.4% of the total. Reporting peaked in 2022 at $6,621 and has fallen 96.2% since, to $252 in 2024. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $650.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$5K
- Luye Pharma (USA) Ltd.$5K
- Teva Pharmaceuticals USA, Inc.$4K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$382
- Axsome Therapeutics, Inc.$126
- plus $181 from 2 others
Across 19 payments — averaging $14,728 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$280K
What the payments were for
- Consulting fees$2,68316%
- Speaking & faculty fees$12,06071%
- Travel & lodging$1,1647%
- Food & beverage$9946%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $4,973 |
| Luye Pharma (USA) Ltd. | 8 | $4,969 |
| Teva Pharmaceuticals USA, Inc. | 2 | $4,310 |
| Otsuka America Pharmaceutical, Inc. | 1 | $1,960 |
| AbbVie(2 entities) | 5 | $382 |
| Axsome Therapeutics, Inc. | 2 | $126 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rykindo$4,814
- AUSTEDO$4,310
- INVEGA SUSTENNA$121
How this compares
$16,901 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Houston
- Matthew BramsHouston$1.5M
- Frank ChenHouston$941K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
- Aaron PetersonHouston$700K
- Ayesha RashidHouston$641K
- Lawrence GinsbergHouston$502K
- Kathy FlanaganHouston$443K
- Rayan Al JurdiHouston$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.